Related Experiment Video
Updated: Nov 11, 2025
11:25
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
Published on: April 1, 2015
13.6K
Very severe aplastic anemia in an 80-year-old man
Ganesh Kasinathan1, Bee Sun Lee1, Jameela Sathar1
1Department of Hematology Ampang Hospital Ampang Malaysia.
Clinical Case Reports
|March 26, 2021
Summary
Elderly patients with very severe aplastic anemia may benefit from standard therapy. However, outcomes depend on pancytopenia severity, paroxysmal nocturnal hemoglobinuria clone presence, and therapy-related infections.
Area of Science:
- Hematology
- Internal Medicine
- Oncology
Background:
- Very severe aplastic anemia (SAA) is a life-threatening condition.
- Standard therapy aims to restore bone marrow function.
- Elderly patients present unique challenges in managing SAA.
Observation:
- Elderly patients with SAA may be candidates for standard treatments.
- Certain clinical factors can predict treatment outcomes.
- Pancytopenia severity and PNH clone status are key indicators.
Findings:
- Severity of pancytopenia is a significant predictor of adverse outcomes.
- The absence of a minor paroxysmal nocturnal hemoglobinuria (PNH) clone is associated with poorer prognosis.
- Infective complications arising from therapy contribute to adverse events.
Implications:
- Risk stratification is crucial for elderly SAA patients.
- Identifying patients at high risk allows for tailored treatment strategies.
- Managing infectious complications is vital for improving survival rates in SAA.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
77
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
77
01:22Bone Marrow Sampling and Transplants
627
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
627
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
131
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
131
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
60
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
60
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
72
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
72
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
72
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
72